BL
GILD icon

BFSG LLC’s Gilead Sciences GILD Stock Holding History

BFSG LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,900
Closed -$211K – 214
2021
Q4 		$211K Buy
+2,900
New +$200K 0.03% 211

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

BFSG LLC's GILD Position: Q2 2026 in Review

BFSG LLC increased its Gilead Sciences (GILD) stake by 7.1% in Q2 2026, buying an estimated $8.17K and bringing the position to 931 shares worth $118K. The position accounts for 0.01% of the portfolio, ranked #350.

BFSG LLC first reported a position in GILD in Q1 2017 and has held it in 24 quarters since. The position peaked at $2.92M in Q2 2020. 536 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BFSG LLC held 931 shares of Gilead Sciences worth $118K as of Q2 2026.
  • BFSG LLC bought 62 Gilead Sciences shares in Q2 2026, an estimated $8.17K.
  • Gilead Sciences made up 0.01% of BFSG LLC's portfolio in Q2 2026, its #350 holding.
  • BFSG LLC first reported a position in Gilead Sciences in Q1 2017 and has held it in 24 quarters since.
  • BFSG LLC's Gilead Sciences position peaked at $2.92M in Q2 2020.
  • 536 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.